TSS:Hg 34030.1

Basic information about the TSS

---

TSS ID: hg_34030.1 Species: human Chr: chr2		Start: 219177138 End: 219177210 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: NM_001321391.2 NR_135628.2 Distance: 0 GeneID: 27013 HGNC/MGI_ID: HGNC:25220 UniProt_ID: Q9BV87

Gene_name: cyclin Pas1/PHO80 domain containing 1 Gene_symbol: CNPPD1 Gene_synonyms: CGI-57 Gene_source: HGNC:25220

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_001321391
Entrez ID:	27013
Nearest Unigene:	Hs.4973
Nearest Refseq:	NM_015680
Nearest Ensembl:	ENSG00000115649
Gene Name:	cyclin Pas1/PHO80 domain containing 1
Gene Alias:	C2orf24|CGI-57
Gene Description:	cyclin Pas1/PHO80 domain containing 1
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CNPPD1 p2@CNPPD1 p3@CNPPD1 p4@CNPPD1
Sample		p1@CNPPD1	p2@CNPPD1	p3@CNPPD1	p4@CNPPD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.92	1.36	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2.43	2.43	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2.51	1.74	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1.46	2.08	1.04	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.47	1.12	0.45	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.26	1.16	0.78	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	3.27	2.40	1.09	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.36	1.94	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.98	1.50	1.07	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.38	2.32	2.32	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.04	3.23	2.83	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.44	2.44	0.81	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.67	4.35	1.61	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.54	4.06	1.05	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.39	7.03	1.10	3.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.83	2.26	1.26	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.01	2.84	0.87	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	4.64	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	2.67	1.60	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.44	2.11	1.05	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.23	3.88	0.94	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.19	3.63	1.73	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.28	1.94	1.03	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	12.13	4.61	1.70	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.93	3.87	1.03	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	5.06	2.85	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	3.30	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.20	4.24	0.94	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.11	3.23	1.13	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.05	2.90	0.90	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.61	2.30	2.09	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.53	3.13	1.37	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.76	3.59	1.48	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.74	3.30	0.99	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.67	3.37	1.12	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	7.28	4.02	1.34	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.22	4.50	0.82	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	4.63	2.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	5.13	1.62	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.60	3.12	1.20	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.06	4.71	1.88	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.00	4.39	1.02	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.17	6.54	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.74	4.37	2.45	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.24	5.02	1.61	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.24	7.21	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.40	4.32	2.16	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.35	5.66	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.29	3.83	2.39	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.10	5.66	2.43	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.22	3.28	1.23	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.56	5.78	2.67	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	4.97	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.94	4.31	0.33	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.84	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	6.43	4.13	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	3.89	1.62	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	10.92	1.93	1.61	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	1.89	2.20	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	1.41	3.53	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	3.36	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	1.59	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.51	2.72	1.02	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.70	3.57	1.95	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.10	4.26	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	2.93	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.89	4.96	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.26	0.94	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.62	1.32	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.66	2.78	1.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	3.67	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	10.14	3.01	1.90	0.79
Adipocyte - breast, donor2	11327-117E4	13.96	4.01	2.41	1.44
Adipocyte - omental, donor1	11473-119C6	9.16	3.82	1.15	0.76
Adipocyte - omental, donor2	11474-119C7	8.22	3.74	0.00	2.24
Adipocyte - omental, donor3	11475-119C8	10.72	2.01	2.01	1.00
Adipocyte - perirenal, donor1	11476-119C9	7.02	3.19	1.91	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	3.30	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	1.81	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	13.90	5.91	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	17.41	3.72	0.39	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	4.38	3.60	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	13.94	4.74	0.00	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	9.99	6.47	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	19.55	5.95	0.16	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	13.56	1.94	0.97	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	18.66	2.67	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.13	4.45	0.00	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	12.48	10.81	1.66	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	12.56	2.01	1.26	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	13.09	3.93	1.31	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	4.26	0.91	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	14.81	2.87	1.33	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	18.65	3.23	0.00	3.23
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	5.99	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	3.78	3.42	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	5.02	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.31	1.64	0.21	1.03
Anulus Pulposus Cell, donor1	11248-116E6	6.18	3.78	0.23	0.23
Anulus Pulposus Cell, donor2	11463-119B5	6.37	2.20	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	2.25	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.21	1.74	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.58	1.49	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	2.64	1.98	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.57	0.65	1.62	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	1.94	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	1.19	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	2.26	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	0.00	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.28	1.98	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1.36	4.09	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.17	1.81	0.30	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.75	1.07	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.37	1.51	0.00	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.61	2.67	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1.95	1.95	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.64	1.99	0.50	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.18	2.57	0.34	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	1.46	1.46	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.35	0.76	1.52	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	2.85	2.28	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.27	1.71	0.21	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.87	3.87	1.03	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	0.47	0.47	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.11	2.25	0.96	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.92	1.75	2.34	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.12	1.20	1.81	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	1.02	0.00	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.37	0.76	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	2.54	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	2.59	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.87	1.48	0.00	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	3.19	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	3.78	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.61	1.53	0.68	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.36	2.57	1.29	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	1.80	1.20	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.13	2.07	0.92	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	7.65	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	3.05	0.25	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.57	2.68	0.21	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	1.84	1.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.26	1.91	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.21	2.22	0.22	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1.66	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.03	2.65	1.32	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	0.73	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	9.46	6.63	1.11	1.35
Astrocyte - cerebellum, donor2	11580-120F5	8.39	4.28	1.37	0.51
Astrocyte - cerebellum, donor3	11661-122F5	10.49	7.76	0.84	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	11.50	3.14	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	10.68	4.21	1.13	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	10.44	5.67	0.45	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	22.59	10.55	0.46	1.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	21.92	11.02	1.25	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	17.52	11.49	0.91	0.80
Basophils, donor1	12241-129G9	14.38	8.89	0.52	1.05
Basophils, donor2	12242-129H1	10.10	3.25	2.16	1.08
Basophils, donor3	12243-129H2	21.46	8.23	0.44	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	22.85	2.59	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	22.40	2.74	0.46	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.67	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.11	3.54	0.62	2.50
Bronchial Epithelial Cell, donor6	11461-119B3	8.98	3.68	0.46	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	10.62	2.70	0.36	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	8.76	5.15	1.65	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	23.29	3.96	1.63	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.87	1.60	1.60	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	11.83	7.33	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	15.03	5.01	1.67	0.74
CD14+ Monocytes, donor3	11381-118B4	18.22	10.54	1.32	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	23.49	6.51	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.50	7.58	0.76	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	30.24	4.27	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	41.20	9.97	2.31	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	24.14	6.94	0.30	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	31.27	11.84	2.61	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.73	8.20	0.84	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.49	8.00	1.38	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	12.15	7.69	0.99	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.24	8.62	1.17	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.44	6.94	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	11.10	6.75	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.96	16.62	0.23	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.81	17.42	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	14.42	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	24.25	6.84	1.93	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	11.17	6.59	1.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.12	9.37	1.25	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	15.10	11.44	0.92	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.82	9.27	1.36	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.53	8.73	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.33	7.80	1.08	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	19.37	9.77	1.74	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.04	10.10	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.78	10.47	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.17	8.10	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	11.41	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.59	8.02	1.39	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.89	5.95	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	11.21	10.78	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	11.47	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.56	8.11	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.87	10.90	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	17.66	6.76	0.65	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	24.25	9.93	0.23	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	17.11	9.10	0.22	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	24.76	11.68	0.31	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	17.81	7.68	0.17	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	9.36	0.22	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	24.50	13.78	0.00	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	19.76	8.56	0.00	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	17.69	10.74	0.42	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	34.55	4.06	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	31.86	27.12	3.39	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	39.35	39.35	0.00	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	34.65	9.06	3.20	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	35.92	21.44	2.68	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.89	28.08	2.81	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	32.94	30.59	5.49	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	35.59	36.91	1.32	3.95
CD19+ B Cells, donor1	11544-120B5	69.04	14.79	8.22	2.47
CD19+ B Cells, donor2	11624-122B4	78.35	11.61	11.61	5.80
CD19+ B Cells, donor3	11705-123B4	73.20	13.63	5.55	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	136.17	9.70	2.42	4.85
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	101.87	9.99	2.80	3.20
CD34+ Progenitors, donor1	11545-120B6	7.03	7.03	0.00	4.02
CD34+ Progenitors, donor2	11625-122B5	7.87	2.81	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.03	2.63	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	10.15	2.71	0.45	1.35
CD4+ T Cells, donor1	11225-116C1	11.07	12.50	1.43	0.71
CD4+ T Cells, donor2	11306-117C1	17.76	13.47	1.22	1.22
CD4+ T Cells, donor3	11382-118B5	14.03	19.21	2.74	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.40	12.25	3.57	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.95	16.17	5.39	2.47
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	22.42	15.24	2.59	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	9.96	20.39	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	10.53	18.96	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	29.67	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.52	11.13	2.31	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.37	11.18	4.74	2.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.50	9.67	3.55	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.83	14.35	3.14	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	16.77	22.01	2.45	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	19.80	14.96	2.64	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	12.23	10.12	1.26	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.78	12.88	2.08	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.70	9.36	1.34	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	11.69	12.24	1.09	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	6.43	16.61	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	21.52	12.55	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	16.69	10.20	2.04	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.66	14.73	2.17	1.95
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	23.54	10.09	3.57	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	13.15	14.66	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	16.46	14.73	2.17	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	13.95	10.46	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	29.69	21.77	2.97	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	15.69	19.39	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	23.73	6.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	27.14	9.69	1.94	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	25.03	18.16	2.21	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	9.24	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	23.64	18.62	3.58	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	30.47	20.77	6.92	2.77
CD8+ T Cells, donor1	11226-116C2	18.01	11.46	2.95	2.29
CD8+ T Cells, donor2	11307-117C2	25.90	14.64	3.38	2.63
CD8+ T Cells, donor3	11383-118B6	17.93	9.85	2.78	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.76	0.92	1.15	3.44
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.38	1.44	1.44	3.83
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.13	1.37	0.27	4.38
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.71	2.10	1.20	3.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.20	4.32	0.96	3.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.28	1.14	1.14	3.18
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.34	1.74	2.17	3.26
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	17.63	0.53	1.84	2.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.71	2.35	1.17	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.49	2.42	0.00	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.42	3.20	0.87	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	14.12	5.33	0.53	3.73
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	3.50	0.44	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.57	5.01	1.37	3.64
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	3.73	1.49	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.45	1.80	1.44	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.59	1.73	1.44	4.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	23.10	3.77	2.36	3.06
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.62	3.49	1.27	6.02
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	18.76	3.69	1.85	5.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.59	3.85	1.28	4.17
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.83	5.74	0.00	3.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.82	4.34	0.79	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	1.51	0.00	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	11.24	6.42	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.19	6.99	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	22.04	7.01	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.93	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	6.73	1.47	0.53	0.74
Chondrocyte - de diff, donor1	11261-116G1	14.91	0.35	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	5.69	2.13	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.20	3.64	1.59	1.48
Chondrocyte - re diff, donor2	11339-117F7	1.79	4.48	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	5.26	4.85	2.02	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	5.85	4.25	0.34	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	6.20	4.49	0.43	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	6.73	2.74	1.06	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.06	12.01	3.85	1.93
Corneal Epithelial Cells, donor1	11526-119I5	16.91	5.49	0.44	1.32
Corneal Epithelial Cells, donor2	11606-120I4	17.06	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.62	2.81	0.51	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.59	1.16	0.33	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	20.19	1.58	0.32	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	25.05	0.54	0.86	2.59
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.37	6.83	2.39	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.32	7.18	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.42	9.19	2.90	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	5.00	2.33	0.50	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	2.35	1.76	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	6.50	1.98	1.13	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	5.11	1.18	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	3.78	2.62	0.29
Endothelial Cells - Artery, donor2	11341-117F9	8.71	4.00	0.47	1.41
Endothelial Cells - Artery, donor3	11413-118E9	6.31	1.58	1.23	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.53	2.22	0.22	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.21	1.52	0.91	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.58	3.38	0.56	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	5.65	3.27	1.19	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	2.08	1.56	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	7.23	3.97	0.28	4.96
Endothelial Cells - Thoracic, donor1	11266-116G6	6.80	4.00	1.20	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	0.00	1.57	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	7.70	3.48	1.49	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	8.26	3.04	1.09	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	7.82	2.44	1.71	1.10
Endothelial Cells - Vein, donor1	11267-116G7	3.41	3.41	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.29	3.49	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	6.91	1.41	0.63	1.26
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	18.15	29.70	3.30	1.65
Eosinophils, donor3	12246-129H5	21.40	21.40	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	15.39	2.44	0.73	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.21	1.23	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.47	0.77	1.09	1.64
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.33	1.52	0.87	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.00	2.18	1.09	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	21.97	3.55	1.36	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.39	1.05	0.63	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.55	2.11	1.58	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	7.31	1.66	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	10.43	2.72	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	5.31	3.03	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	10.41	4.89	1.89	1.58
Fibroblast - Cardiac, donor4	11452-119A3	4.24	1.21	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	5.33	2.41	0.51	0.63
Fibroblast - Cardiac, donor6	11460-119B2	4.55	2.43	0.91	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	5.23	4.56	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	2.16	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.76	7.84	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	3.22	0.51	1.36
Fibroblast - Dermal, donor1	11269-116G9	11.74	0.94	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	4.72	2.83	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.00	1.21	1.09	0.48
Fibroblast - Dermal, donor4	11450-119A1	5.54	2.26	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	4.54	1.22	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	5.68	1.14	1.14	0.32
Fibroblast - Gingival, donor1	11237-116D4	9.79	2.08	0.42	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.79	5.76	1.57	1.31
Fibroblast - Gingival, donor2	11318-117D4	8.96	2.64	0.66	0.92
Fibroblast - Gingival, donor3	11394-118C8	9.96	2.22	0.48	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	7.27	3.12	2.08	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.34	2.64	1.76	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	6.39	4.52	1.56	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	8.11	2.16	1.08	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.06	8.47	1.76	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	5.12	3.51	1.61	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	6.95	4.36	0.55	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	7.35	1.97	0.77	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	7.48	3.52	1.03	0.73
Fibroblast - Lung, donor1	11270-116H1	6.80	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	12.24	2.11	0.63	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	8.33	4.17	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.00	2.24	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	9.34	7.31	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.01	3.30	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	8.19	3.94	0.76	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	11.32	1.22	0.92	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	7.63	0.76	1.53	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.69	0.81	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	6.61	1.62	1.39	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.63	0.99	1.11	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.38	3.66	0.61	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.01	3.34	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.16	1.98	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.69	4.17	2.78	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.88	3.20	1.42	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.10	2.37	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.35	6.32	1.50	3.01
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.18	1.62	1.19	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.54	3.04	2.02	1.52
Fibroblast - skin normal, donor1	11553-120C5	9.02	2.79	1.80	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	19.65	4.41	3.01	2.41
Fibroblast - skin normal, donor2	11561-120D4	9.34	3.92	1.71	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	18.13	4.84	3.02	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.60	2.40	1.16	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.51	3.42	1.54	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.39	4.60	2.63	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.53	2.45	1.28	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	9.28	2.53	1.69	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.49	1.10	1.57	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	1.74	2.61	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.49	1.56	0.52	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.07	1.56	0.26	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.73	0.77	0.77	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.06	3.06	0.77	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.83	2.55	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	6.85	1.14	1.71	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.41	6.89	0.00	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	6.62	12.10	0.00	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	6.34	4.36	0.59	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.02	4.49	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.09	16.31	0.65	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	5.75	1.33	1.77	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	7.49	2.12	0.71	2.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.90	3.20	0.74	2.34
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.18	2.95	0.54	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.95	2.97	0.50	1.98
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.64	1.80	0.28	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	7.32	2.44	0.81	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	9.13	5.48	0.68	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.34	3.24	0.37	2.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	8.09	2.40	0.87	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	6.50	6.21	0.59	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	8.42	2.23	0.48	2.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	8.04	2.90	0.45	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	8.67	5.65	1.01	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.67	3.90	0.68	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	7.80	3.64	0.53	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.97	8.12	0.62	1.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	10.25	7.68	0.51	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	9.29	3.10	1.00	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.57	3.00	1.25	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.82	3.47	0.20	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.49	5.57	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	7.38	5.07	0.46	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	9.67	3.84	1.00	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.60	4.85	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.21	3.69	0.49	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	10.54	3.57	0.81	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.62	5.13	0.96	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	7.11	3.79	0.38	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.39	4.43	0.16	2.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.43	3.04	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	9.83	2.82	0.94	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.81	3.51	0.66	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.50	2.81	0.84	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.31	1.48	1.30	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.10	2.41	1.34	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	8.87	2.60	0.61	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.75	1.94	1.17	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.91	4.61	1.63	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	9.77	4.24	0.55	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.97	2.85	0.44	2.41
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	4.96	0.00	5.95
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	8.71	2.90	0.40	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.47	2.42	1.01	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	39.14	14.23	3.05	5.34
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.56	2.99	0.40	2.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.63	2.31	0.77	2.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.14	2.45	0.20	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.44	1.88	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.70	1.70	0.85	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.07	1.84	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	4.95	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	7.74	3.48	1.55	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	4.81	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.86	4.56	0.98	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.53	4.94	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	2.80	2.24	0.84	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	6.21	4.90	0.65	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	2.52	2.52	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1.91	8.27	0.32	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.06	4.08	0.68	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	3.44	5.73	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	3.85	2.66	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	8.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4.97	4.97	0.00	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	6.44	5.29	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	5.00	5.77	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	2.28	6.52	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	3.34	4.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	3.47	4.62	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	3.08	2.40	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	4.72	6.61	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	4.83	5.43	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	4.07	4.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	4.39	10.37	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2.47	5.92	0.99	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	3.54	10.62	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2.92	11.09	1.17	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	3.07	6.14	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	4.24	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2.39	1.79	1.19	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	4.85	3.88	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	1.14	4.57	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.47	3.33	2.49	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	2.25	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	2.22	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.60	3.34	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.03	0.93	0.93	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.27	2.03	0.34	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	3.19	1.59	0.91	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7.00	1.20	0.87	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.37	0.64	0.86	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.66	1.94	1.08	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	4.86	0.87	0.50	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.46	1.20	0.51	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.52	0.32	0.00	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.04	5.04	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.92	4.76	2.16	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.82	2.47	1.41	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	3.63	0.00	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.12	3.67	0.87	1.05
Hepatocyte, donor1	11523-119I2	14.53	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	6.46	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	11.66	4.91	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3.26	7.83	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.05	3.32	0.35	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.08	0.69	0.96	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	8.31	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	10.01	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	7.69	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	18.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	6.50	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	10.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	11.91	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	8.87	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	12.60	7.56	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	15.50	6.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	4.89	0.00	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	4.20	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	15.27	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	22.16	6.46	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.58	3.30	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	1.81	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	8.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	13.39	9.57	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	3.65	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	31.61	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.28	3.57	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	9.95	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.36	4.94	0.00	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	7.02	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	4.87	0.70	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	24.34	15.49	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	12.21	10.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	25.60	9.60	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	18.01	15.24	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	3.68	0.00	5.52
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	9.08	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	9.52	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.56	1.63	1.22	1.55
Keratinocyte - epidermal, donor2	11349-117G8	9.37	4.10	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	11.36	2.46	1.14	0.85
Keratinocyte - oral, donor1	11251-116E9	16.91	6.02	0.57	1.25
Keratocytes, donor1	11527-119I6	15.13	1.38	0.34	1.72
Keratocytes, donor2	11607-120I5	4.69	2.34	1.17	1.17
Keratocytes, donor3	11688-122I5	4.54	2.37	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	0.00	2.20	4.40
Lens Epithelial Cells, donor1	11529-119I8	6.47	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	11.53	3.81	0.46	0.92
Lens Epithelial Cells, donor3	11690-122I7	5.45	2.02	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.83	2.61	1.54	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.30	3.91	2.23	2.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.24	2.36	1.26	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	1.61	0.00	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.25	2.84	1.26	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.79	3.77	0.97	2.70
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.51	2.05	0.82	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.58	3.03	0.76	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.49	3.66	0.84	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	2.37	0.79	3.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.27	4.07	0.78	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.22	4.26	1.11	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.57	3.48	0.70	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.72	1.91	0.72	2.62
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.77	3.57	0.41	2.61
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.47	1.23	0.92	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	4.99	0.31	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.42	4.03	0.91	3.84
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.90	1.97	0.33	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	2.93	0.29	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.47	4.73	2.99	4.23
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.33	2.91	0.00	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.31	2.96	0.81	2.15
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.81	3.94	0.61	2.27
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	1.04	1.04	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.07	3.77	0.84	2.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.52	3.76	1.50	2.71
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	2.75	0.00	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.27	2.07	1.32	2.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.48	2.54	1.59	1.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.69	1.94	1.45	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	2.98	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.43	3.96	0.99	3.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	4.44	4.07	1.85	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.71	2.47	1.48	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.32	5.22	0.96	2.75
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.43	2.25	1.29	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.00	3.65	0.91	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.16	2.66	0.98	3.08
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	2.84	0.71	4.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.39	2.42	1.45	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.94	2.65	1.71	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.01	2.51	1.43	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	4.57	0.00	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	3.06	2.35	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.54	2.72	1.24	2.97
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.89	2.31	1.02	2.56
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.27	2.98	2.09	4.48
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	15.86	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	18.41	11.51	1.53	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	6.68	1.48	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.00	10.58	2.54	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.10	13.36	2.11	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	7.47	2.80	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	7.21	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	5.95	2.38	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.64	8.60	1.58	3.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	20.07	7.85	1.74	4.07
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.11	6.75	1.35	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.79	10.03	2.71	4.34
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.97	9.24	1.03	4.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.70	6.70	2.12	3.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	4.66	2.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	12.23	1.02	4.58
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.54	5.34	1.87	3.74
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	19.27	7.94	3.21	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	15.34	3.07	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	8.15	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.74	7.08	2.29	3.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.10	6.73	1.96	4.48
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	10.30	3.09	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.45	7.26	1.16	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.44	6.88	1.49	5.98
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.13	4.43	2.21	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.56	9.54	1.06	4.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.38	10.69	2.58	4.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	8.06	3.45	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.96	14.20	1.15	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.38	10.76	2.26	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	13.95	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	13.10	1.36	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	11.49	10.77	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.17	8.22	0.75	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	27.13	12.26	2.97	4.09
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.38	9.48	0.86	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	10.28	3.43	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.98	11.99	1.33	5.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	9.05	1.21	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	9.24	0.71	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.37	10.31	1.37	4.81
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.91	10.20	1.61	3.76
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.26	7.41	1.35	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.82	13.33	0.74	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	5.81	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	19.04	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.81	10.00	1.60	4.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	13.08	4.36	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.19	14.56	0.77	6.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.24	15.29	2.47	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	9.41	1.88	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.15	10.56	2.51	5.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.43	10.36	2.70	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	5.16	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.95	9.80	0.89	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.63	12.51	0.78	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	7.26	1.32	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	26.47	9.34	0.00	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	26.69	4.38	2.63	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	15.65	4.47	2.24	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	19.87	7.51	1.77	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.14	7.71	2.31	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	4.56	1.52	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.11	7.21	1.44	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.27	5.57	2.39	5.96
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	14.58	6.68	1.82	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	9.68	4.15	1.38	8.30
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.14	5.32	1.52	5.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.98	4.13	3.61	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.70	6.65	1.21	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.50	7.29	3.80	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	10.66	1.07	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	8.05	1.15	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	7.20	1.54	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	22.64	10.61	0.71	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.29	6.24	1.13	6.81
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	29.54	8.74	2.50	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	16.44	10.96	2.35	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.46	10.44	1.25	6.68
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.02	6.97	2.32	6.50
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	6.02	0.00	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.92	9.09	1.60	4.28
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.84	9.70	1.62	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	21.11	11.01	1.84	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	6.22	0.89	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.77	8.55	2.85	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	8.44	0.00	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.79	8.75	1.64	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.05	8.46	0.89	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.66	6.24	1.56	2.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.89	10.61	2.65	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	4.16	0.00	6.24
Macrophage - monocyte derived, donor1	11232-116C8	12.31	3.42	0.46	0.68
Macrophage - monocyte derived, donor2	11313-117C8	8.62	1.65	1.10	0.37
Macrophage - monocyte derived, donor3	11389-118C3	12.71	1.44	0.66	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	1.59	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	8.87	1.11	1.11	0.63
Mallassez-derived cells, donor3	11930-125I4	8.06	1.25	0.42	1.39
Mammary Epithelial Cell, donor1	11273-116H4	12.85	2.59	0.80	2.89
Mammary Epithelial Cell, donor2	11350-117G9	9.84	2.03	0.29	4.34
Mammary Epithelial Cell, donor3	11422-118F9	11.47	2.00	1.00	1.50
Mast cell - stimulated, donor1	11487-119E2	2.71	0.68	2.03	0.68
Mast cell, donor1	11563-120D6	22.28	7.79	2.38	2.05
Mast cell, donor2	11565-120D8	19.32	12.48	0.89	1.19
Mast cell, donor3	11566-120D9	16.66	12.83	0.45	0.68
Mast cell, donor4	11567-120E1	19.86	9.57	0.18	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	11.64	5.99	1.00	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	9.92	4.09	2.33	1.17
Mast cell, expanded, donor5	11939-126A4	14.80	4.13	1.49	1.03
Mast cell, expanded, donor8	11941-126A6	19.08	11.21	3.51	3.51
Melanocyte - dark, donor1	11502-119F8	8.06	2.29	1.09	5.57
Melanocyte - dark, donor2	11582-120F7	3.11	2.77	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	31.58	2.68	4.49	1.88
Melanocyte - light, donor1	11274-116H5	8.46	2.59	0.71	0.71
Melanocyte - light, donor2	11351-117H1	22.52	5.46	1.36	2.05
Melanocyte - light, donor3	11423-118G1	14.74	2.60	1.73	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	22.18	1.35	7.08	2.08
Melanocyte, donor2 (MC+2)	12739-135I3	18.83	0.81	6.19	2.69
Melanocyte, donor3 (MC+3)	12837-137B2	30.00	3.75	10.18	3.21
Meningeal Cells, donor1	11493-119E8	5.95	4.22	1.24	0.12
Meningeal Cells, donor2	11573-120E7	1.76	5.28	0.44	0.44
Meningeal Cells, donor3	11654-122E7	4.97	2.45	1.39	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.41	2.57	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.84	1.31	0.70	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	21.03	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	2.62	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.18	1.44	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.92	1.91	1.69	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.06	1.51	2.01	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.25	2.42	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	5.11	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.93	4.50	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.51	1.25	0.55	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.78	7.06	1.12	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6.45	4.08	0.92	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	3.56	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.12	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	1.06	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	6.25	1.56	0.00	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.08	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	9.81	1.33	1.86	0.80
Mesothelial Cells, donor2	12156-128G5	6.51	0.50	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	9.83	0.94	2.31	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	5.40	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.81	4.68	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	1.77	0.00	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.68	1.86	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.92	1.45	0.83	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	2.50	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	1.40	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.60	1.22	0.41	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	0.40	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	6.19	1.77	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.98	2.66	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.52	2.33	1.06	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	0.00	0.00	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	1.49	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.53	2.01	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.47	1.19	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.22	1.84	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.10	0.63	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.93	1.43	0.20	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.37	1.93	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.11	1.56	0.44	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.45	1.75	0.66	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	2.03	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.98	1.36	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.59	0.88	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	2.88	0.48	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.81	0.80	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.51	2.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.14	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	1.28	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.91	1.98	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.38	1.03	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	0.00	0.00	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.81	1.07	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.67	3.93	1.68	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.81	0.42	0.83	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.26	0.60	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	0.42	0.42	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.24	1.14	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.01	1.52	0.00	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.63	2.59	0.78	2.33
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	2.14	0.43	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.07	1.07	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.08	1.50	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	1.55	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.28	2.87	1.27	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.06	2.43	1.11	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	1.52	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.95	0.85	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.82	2.46	0.74	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	1.30	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	1.18	0.29	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.67	3.17	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	6.18	2.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.85	2.08	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.37	4.27	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	1.05	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.85	4.15	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	4.51	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.38	4.53	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.07	2.38	0.23	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	3.68	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.02	3.66	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	6.06	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.75	1.69	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	8.17	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	2.54	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	4.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	9.06	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	45.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.97	1.72	0.86	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.84	3.14	2.09	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	1.33	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.59	0.83	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	3.04	0.38	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	6.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	1.36	2.04	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.60	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.97	2.09	1.86	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.51	1.89	0.81	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	4.63	2.10	0.84	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.96	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.98	1.89	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.16	2.27	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.27	0.82	0.49	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.20	0.91	0.36	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	1.06	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	3.60	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	3.61	0.98	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.72	1.63	0.65	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.76	1.76	1.23	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	1.41	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	0.46	1.84	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	0.96	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2.76	0.69	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.24	1.11	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.08	0.00	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2.37	0.47	0.71	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	1.29	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.66	1.33	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.96	0.00	1.35	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	2.38	0.79	1.19	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	4.54	1.51	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.56	1.30	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	3.49	0.44	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	4.98	1.36	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	0.00	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	0.99	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	5.74	1.15	1.15	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.89	5.75	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	3.76	0.88	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	2.03	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	0.63	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.87	2.12	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2.37	0.79	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.57	0.99	0.99	0.62
Myoblast, donor2	11322-117D8	9.78	3.07	0.58	0.58
Myoblast, donor3	11398-118D3	7.90	0.84	0.50	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.50	7.44	1.75	3.65
Natural Killer Cells, donor1	11230-116C6	24.60	11.07	2.46	3.08
Natural Killer Cells, donor2	11311-117C6	20.51	13.87	3.62	1.81
Natural Killer Cells, donor3	11387-118C1	21.53	13.07	2.76	2.94
Neural stem cells, donor1	11275-116H6	7.62	3.27	1.45	0.36
Neural stem cells, donor2	11352-117H2	9.63	1.93	1.93	1.93
Neurons, donor1	11494-119E9	10.24	12.52	12.52	0.00
Neurons, donor2	11574-120E8	12.77	2.64	5.94	0.66
Neurons, donor3	11655-122E8	14.80	3.29	4.93	0.82
Neutrophils, donor1	11233-116C9	22.27	29.70	0.00	0.93
Neutrophils, donor2	11314-117C9	11.60	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	18.94	37.87	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	6.89	4.27	0.36	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	5.54	5.54	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.02	1.20	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	10.32	1.24	1.24	0.96
Olfactory epithelial cells, donor2	11934-125I8	11.15	2.32	1.45	1.16
Olfactory epithelial cells, donor3	11935-125I9	9.99	2.72	1.14	1.25
Olfactory epithelial cells, donor4	11936-126A1	11.10	1.95	0.78	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	1.81	0.60	2.41
Osteoblast - differentiated, donor1	11276-116H7	7.02	1.70	0.64	0.64
Osteoblast - differentiated, donor2	11353-117H3	16.00	1.14	2.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	18.00	4.34	0.62	1.24
Osteoblast, donor1	11277-116H8	9.19	3.52	0.78	0.59
Osteoblast, donor2	11354-117H4	9.13	4.21	2.11	0.70
Osteoblast, donor3	11426-118G4	8.18	4.09	0.53	0.89
Pancreatic stromal cells, donor1	11249-116E7	12.64	2.27	1.01	0.67
Pericytes, donor1	11491-119E6	7.79	6.68	1.45	0.78
Pericytes, donor2	11571-120E5	7.47	6.56	0.45	0.23
Pericytes, donor3	11652-122E5	6.51	5.49	0.20	0.41
Perineurial Cells, donor1	11499-119F5	7.69	2.37	0.90	0.45
Perineurial Cells, donor2	11579-120F4	4.23	2.76	0.37	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	17.53	8.29	3.51	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	21.06	7.35	1.47	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.98	6.47	1.94	2.46
Placental Epithelial Cells, donor1	11278-116H9	15.31	7.41	3.11	1.67
Placental Epithelial Cells, donor2	11355-117H5	8.87	7.76	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	5.69	5.89	0.39	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	0.63	1.58	0.63
Preadipocyte - breast, donor1	11467-119B9	5.06	2.44	1.88	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	17.23	2.09	2.22	1.57
Preadipocyte - breast, donor2	11328-117E5	12.61	2.03	1.35	1.13
Preadipocyte - omental, donor1	11468-119C1	9.48	2.34	1.28	1.70
Preadipocyte - omental, donor2	11329-117E6	16.15	2.62	0.44	1.75
Preadipocyte - omental, donor3	11403-118D8	11.46	1.43	0.57	0.86
Preadipocyte - perirenal, donor1	11469-119C2	2.95	1.97	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	3.99	3.07	0.31	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	11.69	0.89	1.59	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	10.73	1.87	0.51	1.02
Preadipocyte - visceral, donor1	11280-116I2	13.04	1.58	0.65	1.40
Preadipocyte - visceral, donor2	11357-117H7	7.82	1.38	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	8.46	1.57	0.52	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	14.63	5.43	0.15	2.26
Prostate Epithelial Cells, donor2	11331-117E8	9.75	1.49	1.22	1.35
Prostate Epithelial Cells, donor3	11404-118D9	12.92	1.10	0.49	0.43
Prostate Stromal Cells, donor1	11254-116F3	8.77	2.28	0.46	0.57
Prostate Stromal Cells, donor2	11332-117E9	13.45	1.79	1.79	0.72
Prostate Stromal Cells, donor3	11405-118E1	13.14	3.34	1.15	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.52	6.20	1.82	3.65
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.88	0.97	0.90	1.46
Renal Epithelial Cells, donor1	11517-119H5	10.65	7.10	1.01	1.52
Renal Epithelial Cells, donor2	11597-120H4	14.23	4.27	0.71	3.56
Renal Epithelial Cells, donor3	11678-122H4	9.85	1.59	1.16	1.16
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.85	4.77	0.00	5.45
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.74	2.83	0.40	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	3.77	2.00	1.11	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.31	7.32	2.66	3.99
Renal Mesangial Cells, donor1	11518-119H6	9.68	6.16	1.32	1.10
Renal Mesangial Cells, donor2	11598-120H5	10.66	5.02	0.00	1.88
Renal Mesangial Cells, donor3	11679-122H5	13.59	7.21	1.39	3.61
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	17.98	2.15	1.34	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	4.64	1.27	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.15	4.44	0.96	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.89	1.04	1.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.81	8.81	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	5.15	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.55	6.27	2.76	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.11	3.88	1.07	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	6.25	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	1.10	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	6.38	3.48	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.31	1.82	2.08	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.70	4.17	2.98	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	12.72	4.80	2.68	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.75	1.49	1.98	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	19.00	3.03	2.91	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	14.56	3.70	2.08	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.50	2.19	1.78	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.10	3.33	1.97	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	12.01	4.12	2.33	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.05	2.58	2.30	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.67	4.08	2.68	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.61	3.10	2.88	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.26	2.49	2.68	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.56	3.35	2.61	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	10.71	3.95	3.38	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.16	2.26	1.59	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.07	3.89	2.34	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	14.70	4.58	3.82	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	11.53	2.56	1.60	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.70	4.20	1.96	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.42	3.08	3.42	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	8.93	2.73	2.37	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.15	3.31	3.80	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.64	3.49	4.30	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.61	2.83	3.54	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	15.28	4.37	1.98	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	13.33	3.51	2.10	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.75	3.11	4.15	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	14.16	2.88	4.20	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	13.79	4.80	3.13	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.27	2.29	4.58	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	10.73	5.28	3.58	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	13.88	2.89	3.28	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.86	3.44	3.27	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.64	3.70	3.84	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.81	4.10	3.78	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.40	1.19	2.39	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.31	3.85	2.81	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.39	2.40	3.20	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	13.27	2.90	2.49	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.43	2.38	2.62	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.74	3.02	1.21	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.35	2.45	2.07	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.07	1.40	1.05	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	14.81	3.32	1.51	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	20.68	2.81	1.47	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.05	3.64	2.91	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	14.60	2.43	2.43	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.45	4.22	1.51	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.24	4.30	4.98	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.86	5.39	3.29	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.26	3.42	3.07	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.12	3.84	5.76	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.03	4.21	3.00	4.21
Schwann Cells, donor1	11498-119F4	7.33	6.02	0.94	0.38
Schwann Cells, donor2	11578-120F3	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	5.26	4.82	0.66	0.66
Sebocyte, donor1	11220-116B5	14.24	2.74	2.19	1.10
Sebocyte, donor2	11301-117B5	10.11	1.84	1.38	1.84
Sebocyte, donor3	11378-118B1	12.99	4.33	1.03	1.03
Sertoli Cells, donor1	11255-116F4	18.22	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	10.03	3.87	1.06	0.70
Skeletal Muscle Cells, donor2	11358-117H8	17.35	6.51	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	15.88	10.03	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	4.56	3.14	0.47	0.31
Skeletal Muscle Cells, donor5	11455-119A6	4.01	4.31	0.59	0.45
Skeletal Muscle Cells, donor6	11459-119B1	4.31	1.39	1.08	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	5.04	4.79	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	5.42	3.85	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.45	1.88	0.69	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.53	3.88	0.25	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	4.34	1.45	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.60	2.34	0.96	0.55
Skin - palm, donor1	10286-104F7	2.69	2.69	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.05	1.30	1.15	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	4.91	2.45	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.67	1.17	0.13	2.08
Small Airway Epithelial Cells, donor1	11256-116F5	11.40	1.81	0.97	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	9.00	1.97	1.13	2.39
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	27.49	4.44	1.06	5.50
Small Airway Epithelial Cells, donor3	11406-118E2	15.14	1.80	0.67	1.20
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.10	0.93	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.35	3.33	2.67	3.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.99	2.94	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.19	1.10	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.88	0.39	2.36	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	6.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.79	2.13	0.80	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.97	1.11	1.11	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.19	2.18	1.15	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.88	3.26	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	5.32	1.77	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.40	0.57	1.14	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.27	3.58	0.49	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.74	4.26	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.82	4.55	0.76	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	4.77	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	5.16	2.21	0.15	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	3.87	1.51	0.22	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	3.99	1.26	0.63	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.89	1.86	1.39	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	19.40	5.39	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.68	0.30	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.19	3.41	1.02	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	5.10	2.36	0.16	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.98	1.61	1.11	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.93	1.59	1.37	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	6.62	1.32	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.39	3.73	1.20	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.63	1.88	0.75	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.70	1.01	0.76	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.90	2.71	0.60	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	5.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.30	2.33	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.11	3.03	0.50	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.60	2.19	2.51	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.49	1.18	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7.00	1.58	0.50	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.01	0.47	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.79	1.15	1.30	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.02	4.59	1.02	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.45	3.20	1.69	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	3.49	1.26	0.70	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	5.61	1.42	0.67	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	4.76	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.05	0.98	0.73	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.95	2.65	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.07	2.93	1.46	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.03	1.17	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.67	1.06	1.06	3.70
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.95	0.74	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.78	2.16	2.16	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.23	1.14	1.99	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.91	1.58	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	4.83	0.76	0.00	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	4.79	1.20	1.60	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	6.27	0.42	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	7.79	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	8.75	1.85	0.67	0.34
Synoviocyte, donor2	11368-117I9	16.76	1.68	0.50	2.35
Synoviocyte, donor3	11440-118H9	6.48	1.56	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	11.43	6.79	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.97	7.64	0.93	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	6.95	1.43	0.72	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	8.12	1.16	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	0.57	1.15	4.01
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.07	4.43	0.98	0.98
Urethra, donor2	10319-105A4	14.39	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	12.22	2.39	0.53	0.80
Urothelial Cells, donor2	11600-120H7	10.41	1.20	0.40	0.80
Urothelial Cells, donor3	11681-122H7	13.98	3.44	0.69	1.15
Urothelial cells, donor0	11216-116B1	14.93	2.45	0.67	3.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	97.88	13.35	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	142.96	22.87	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	89.67	11.64	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	35.47	12.05	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	14.53	1.74	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	72.89	16.66	2.08	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	84.44	18.36	1.84	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	106.81	11.87	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	7.40	2.47	0.12	1.23
Wilms' tumor cell line:HFWT	10597-108E3	16.72	2.64	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.06	1.40	0.28	1.68
achilles tendon, donor2	10292-104G4	16.53	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	25.50	7.39	2.04	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	10.45	4.41	1.63	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	10.80	7.36	1.19	2.37
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.16	11.16	1.90	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.30	3.37	1.69	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.05	2.54	0.42	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.07	3.54	1.91	4.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.53	2.20	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	14.70	5.72	1.23	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	17.86	3.49	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.83	4.78	0.55	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.25	6.04	1.86	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	9.32	3.11	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	11.11	5.55	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.51	3.72	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	14.39	2.06	1.65	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.22	2.15	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	12.80	5.55	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.34	3.34	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	13.00	4.81	1.20	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	9.80	3.79	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.34	5.67	0.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	5.57	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	29.00	4.52	1.51	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	10.90	2.62	1.74	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	13.42	2.35	0.00	0.94
adipose tissue, adult, pool1	10010-101C1	15.67	5.74	0.16	2.48
adipose, donor1	10184-103D4	4.10	3.52	0.59	0.00
adipose, donor2	10185-103D5	5.27	15.00	0.00	0.41
adipose, donor3	10186-103D6	8.44	11.71	0.54	1.36
adipose, donor4	10187-103D7	3.47	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	16.10	2.53	0.79	0.79
adrenal gland, adult, pool1	10081-102A9	18.19	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	21.75	13.61	0.80	3.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	12.15	3.22	0.36	1.79
amniotic membrane cells, donor1	12235-129G3	15.53	3.71	1.39	1.39
amniotic membrane cells, donor2	12236-129G4	12.51	7.78	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	10.61	2.65	0.29	0.00
amygdala - adult, donor10196	10167-103B5	4.74	2.37	2.37	1.19
amygdala, adult, donor10252	10151-102I7	19.47	2.84	3.24	0.41
amygdala, newborn, donor10223	10360-105E9	6.46	1.29	1.61	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	8.28	2.29	0.89	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9.93	1.76	1.10	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.35	3.01	0.67	3.34
aorta, adult, pool1	10052-101G7	22.16	2.75	1.57	1.57
appendix, adult	10189-103D9	27.56	2.72	0.00	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	10.66	3.44	1.72	3.10
artery, adult	10190-103E1	14.95	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	7.53	2.03	0.58	0.43
b cell line:RPMI1788	10427-106D4	10.11	5.80	0.59	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.98	0.55	1.66	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.92	2.88	0.40	3.47
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	1.00	0.33	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.66	3.36	0.56	0.00
bladder, adult, pool1	10011-101C2	24.99	3.04	1.09	1.63
blood, adult, pool1	10053-101G8	50.94	6.64	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	0.86	0.86	0.00
bone marrow, adult	10192-103E3	15.52	2.02	0.67	0.00
brain, adult, donor1	10084-102B3	13.33	0.00	12.30	0.00
brain, adult, pool1	10012-101C3	13.47	3.23	8.91	0.78
brain, fetal, pool1	10085-102B4	32.06	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.87	2.31	1.98	3.63
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.85	6.49	1.00	1.00
breast, adult, donor1	10080-102A8	18.31	2.53	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.54	2.41	0.38	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	11.13	4.64	0.31	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.27	1.15	0.46	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.10	1.69	1.21	1.69
carcinoid cell line:NCI-H1770	10703-109H1	6.58	6.11	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	18.59	1.20	2.30	5.69
carcinoid cell line:SK-PN-DW	10719-109I8	3.49	1.27	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.37	7.19	2.13	2.13
caudate nucleus - adult, donor10196	10177-103C6	9.21	1.15	5.76	0.00
caudate nucleus, adult, donor10252	10164-103B2	15.06	3.35	1.51	1.00
caudate nucleus, adult, donor10258	10379-105H1	6.11	4.58	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	5.13	2.56	1.46	0.37
cerebellum - adult, donor10196	10173-103C2	32.05	2.91	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	22.85	5.55	4.91	1.49
cerebellum, adult, pool1	10083-102B2	13.11	2.07	4.83	3.10
cerebellum, newborn, donor10223	10357-105E6	9.13	6.64	8.30	1.66
cerebral meninges, adult	10188-103D8	9.33	2.52	2.02	0.76
cerebrospinal fluid, donor2	10294-104G6	2.92	0.00	2.92	0.73
cervical cancer cell line:D98-AH2	10552-107I3	7.76	1.58	0.29	1.29
cervical cancer cell line:ME-180	10553-107I4	12.43	1.49	2.15	1.82
cervix, adult, pool1	10013-101C4	18.06	2.83	1.57	2.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.64	2.09	2.09	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	2.61	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	8.82	5.22	0.00	1.12
choriocarcinoma cell line:SCH	10785-110H2	6.16	3.33	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	8.06	3.32	0.71	0.24
chorionic membrane cells, donor1	12238-129G6	11.68	3.42	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	11.24	2.88	1.39	0.50
chorionic membrane cells, donor3	12240-129G8	13.74	2.75	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	15.15	3.03	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.98	2.31	1.15	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.88	1.27	0.63	2.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	7.45	3.34	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	11.85	4.60	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.14	3.66	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	15.02	1.47	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.55	3.65	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.23	1.83	0.46	1.14
clear cell carcinoma cell line:TEN	10636-108I6	5.55	2.08	0.35	1.04
colon carcinoma cell line:CACO-2	10513-107D9	15.38	3.66	0.18	4.58
colon carcinoma cell line:COLO-320	10420-106C6	9.50	4.18	0.38	3.04
colon, adult, donor1	10082-102B1	44.03	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	33.72	2.82	0.82	2.70
colon, fetal, donor1	10070-101I7	25.34	1.85	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	14.02	2.12	0.00	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.34	3.62	0.75	2.41
cord blood derived cell line:COBL-a untreated	10449-106F8	11.84	2.82	0.99	2.40
corpus callosum, adult, pool1	10042-101F6	22.78	8.29	26.98	0.66
cruciate ligament, donor2	10295-104G7	7.29	1.62	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	16.85	1.61	1.61	1.61
diencephalon, adult	10193-103E4	12.48	1.92	13.92	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.10	5.51	1.84	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	7.18	2.31	0.51	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.85	2.65	0.72	1.93
ductus deferens, adult	10196-103E7	14.45	3.99	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	6.62	2.94	1.47	3.68
dura mater, adult, donor1	10041-101F5	16.77	5.78	1.40	1.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	10.66	2.22	1.55	2.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	4.01	3.30	0.57	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	6.17	1.23	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	6.66	1.82	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.34	2.47	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	10.51	3.94	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	4.69	1.34	0.00	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	16.49	4.53	1.27	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.96	3.06	2.25	1.61
epidermoid carcinoma cell line:A431	10426-106D3	8.78	1.78	0.56	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.87	1.32	1.10	4.18
epididymis, adult	10197-103E8	18.84	6.70	1.26	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.14	3.90	0.89	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.90	2.36	0.00	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	7.34	1.05	0.79	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.43	1.97	0.39	2.76
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	7.73	1.57	0.56	2.46
esophagus, adult, pool1	10015-101C6	35.89	1.59	1.17	3.93
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.03	2.00	0.25	2.13
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	17.86	1.49	0.00	2.98
eye - muscle superior, donor2	10297-104G9	14.90	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	5.83	4.37	0.00	2.91
eye, fetal, donor1	10054-101G9	16.53	2.80	0.51	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	6.67	0.90	1.03	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.50	1.66	0.95	4.51
frontal lobe, adult, pool1	10040-101F4	11.35	2.72	5.63	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.31	0.30	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.95	2.38	0.09	1.19
gall bladder, adult	10198-103E9	23.18	4.10	2.17	1.45
gamma delta positive T cells, donor1	11937-126A2	17.72	14.50	1.61	1.61
gamma delta positive T cells, donor2	11938-126A3	18.30	11.20	3.36	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.98	2.53	0.42	2.53
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.05	1.74	0.39	0.97
gastric cancer cell line:AZ521	10549-107H9	9.18	6.23	0.33	0.66
gastric cancer cell line:GSS	10560-108A2	7.32	7.32	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	23.07	3.66	3.88	4.34
giant cell carcinoma cell line:LU65	10487-107B1	5.05	0.57	0.34	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	9.10	0.98	0.14	1.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.23	2.24	0.75	3.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.23	7.71	0.95	2.22
glioblastoma cell line:A172, tech_rep2	10444-106F3	6.18	6.60	1.12	1.69
glioblastoma cell line:T98G	10485-107A8	6.95	5.19	0.22	2.10
glioma cell line:GI-1	10413-106B8	6.15	2.93	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	8.75	2.92	18.95	0.73
globus pallidus, adult, donor10252	10161-103A8	28.56	5.13	7.32	0.24
globus pallidus, adult, donor10258	10367-105F7	12.32	1.37	24.65	0.00
globus pallidus, newborn, donor10223	10364-105F4	7.46	3.73	2.13	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	4.89	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.72	0.64	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	1.84	2.75	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	2.74	2.29	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	1.93	1.93	1.29
hIPS, biol_rep1	14380-156B6	2.87	1.44	1.44	1.44
hIPS, biol_rep2	14381-156B7	4.80	4.12	0.69	1.37
hIPS, biol_rep3	14382-156B8	5.52	4.41	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	16.09	8.33	0.86	3.16
heart - mitral valve, adult	10205-103F7	12.56	2.39	1.49	0.60
heart - pulmonic valve, adult	10206-103F8	13.34	2.61	1.57	0.78
heart - tricuspid valve, adult	10207-103F9	9.16	1.67	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	11.43	3.06	0.00	1.63
heart, adult, diseased, donor1	10051-101G6	19.16	3.41	0.85	1.70
heart, adult, pool1	10016-101C7	15.18	3.68	1.15	1.84
heart, fetal, pool1	10046-101G1	23.21	1.85	0.41	4.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.48	0.31	0.93	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	3.57	1.19	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.01	4.64	0.44	2.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	22.82	4.61	0.61	2.18
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.93	5.96	1.01	2.53
hepatoma cell line:Li-7	10484-107A7	6.56	0.89	0.44	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.19	6.83	1.21	3.12
hippocampus - adult, donor10196	10169-103B7	9.46	0.95	4.73	1.89
hippocampus, adult, donor10252	10153-102I9	20.00	3.06	2.25	0.00
hippocampus, adult, donor10258	10374-105G5	1.99	1.49	5.98	0.00
hippocampus, newborn, donor10223	10363-105F3	2.82	2.82	2.82	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4.88	1.22	3.05	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.48	1.77	0.59	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	3.05	4.06	0.76	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3.95	7.33	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.65	4.91	0.00	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2.66	6.45	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.17	22.48	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.40	21.54	0.22	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	4.17	25.86	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.81	10.18	1.66	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.16	12.86	0.48	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	8.75	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	5.01	3.13	0.63	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4.42	2.46	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	2.48	5.54	0.19	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.11	4.80	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1.50	5.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	7.54	20.16	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.64	23.19	0.00	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	3.76	20.67	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.14	10.12	1.14	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.71	10.74	1.74	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	5.38	8.97	2.39	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	6.10	2.22	0.37	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.42	2.28	0.00	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2.86	1.63	0.41	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	7.04	4.93	0.35	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	4.43	4.43	0.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	4.24	6.05	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	27.92	0.52	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	15.28	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.39	15.39	0.51	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.18	10.74	1.28	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	11.36	3.03	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	4.70	10.75	1.34	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.83	1.93	0.97	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2.23	2.67	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.88	0.98	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.06	7.03	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.32	6.95	0.00	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	16.97	38.86	0.55	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.43	27.14	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	5.34	26.69	0.36	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	5.97	13.13	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.67	15.98	1.63	1.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	5.12	11.58	0.54	0.27
immature langerhans cells, donor1	11904-125F5	9.93	2.18	0.73	0.97
immature langerhans cells, donor2	11905-125F6	11.88	5.54	0.00	1.58
insula, adult, pool1	10039-101F3	11.92	3.97	4.73	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	18.86	9.75	1.95	1.30
kidney, adult, pool1	10017-101C8	59.38	3.70	2.00	8.41
kidney, fetal, pool1	10045-101F9	38.20	4.03	1.34	4.17
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.24	1.56	0.28	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.33	0.69	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	9.36	0.18	0.92	1.83
left atrium, adult, donor1	10079-102A7	14.17	1.09	0.00	2.18
left ventricle, adult, donor1	10078-102A6	13.65	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	16.69	1.37	0.00	1.37
leiomyoma cell line:10964C	10569-108B2	16.17	2.51	0.36	3.23
leiomyoma cell line:15242A	10570-108B3	20.65	5.98	4.35	4.35
leiomyoma cell line:15425	10571-108B4	12.38	2.43	0.97	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	2.09	3.14	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.42	2.24	0.71	1.65
liposarcoma cell line:KMLS-1	10782-110G8	10.93	5.15	0.47	1.09
liposarcoma cell line:SW 872	10726-110A6	5.60	2.80	1.34	1.83
liver, adult, pool1	10018-101C9	17.99	5.02	0.16	0.97
liver, fetal, pool1	10086-102B5	15.99	2.82	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	7.44	2.92	8.90	0.44
locus coeruleus, adult, donor10252	10165-103B3	20.30	2.95	6.46	0.18
locus coeruleus, adult, donor10258	10375-105G6	10.16	3.67	12.13	1.41
locus coeruleus, newborn, donor10223	10362-105F2	7.57	1.26	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	6.64	1.80	0.83	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	4.14	0.69	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	9.36	1.98	0.13	2.50
lung, adult, pool1	10019-101D1	14.53	5.55	0.47	1.06
lung, fetal, donor1	10068-101I5	15.41	3.42	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	25.66	4.12	1.83	2.75
lymph node, adult, donor1	10077-102A5	17.51	4.73	0.95	1.89
lymphangiectasia cell line:DS-1	10727-110A7	12.05	3.51	0.66	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.87	3.92	1.81	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	23.79	1.70	3.40	4.25
mature adipocyte, donor1	12231-129F8	12.43	7.55	0.89	0.44
mature adipocyte, donor2	12232-129F9	15.56	7.89	0.42	0.62
mature adipocyte, donor3	12233-129G1	17.07	7.59	1.19	0.24
mature adipocyte, donor4	12234-129G2	16.32	3.69	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.68	5.24	1.43	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	2.26	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	17.66	2.76	4.41	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	9.21	1.27	4.45	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	2.99	1.71	1.28	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	7.93	1.69	5.23	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	17.19	2.55	6.15	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	13.48	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2.87	1.08	1.79	1.08
medulla oblongata - adult, donor10196	10174-103C3	8.44	1.30	7.79	0.00
medulla oblongata, adult, donor10252	10155-103A2	24.30	3.25	4.02	0.62
medulla oblongata, adult, pool1	10038-101F2	16.41	4.90	9.80	0.82
medulla oblongata, newborn, donor10223	10361-105F1	6.94	1.39	2.78	0.69
medulloblastoma cell line:D283 Med	10838-111E1	6.64	2.66	0.00	2.66
medulloblastoma cell line:ONS-76	10759-110E3	7.34	2.45	0.37	0.49
melanoma cell line:COLO 679	10514-107E1	11.07	2.44	0.00	1.29
melanoma cell line:G-361	10465-106H6	11.40	2.17	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	6.33	0.72	0.36	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	12.34	7.05	0.88	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	9.33	9.85	1.81	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.59	2.15	0.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.36	1.64	0.36	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.48	0.83	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	9.55	0.70	1.26	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.82	1.16	0.96	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.25	0.69	1.03	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.62	0.81	0.69	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.37	1.99	0.27	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.48	0.27	0.68	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.80	1.85	0.71	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	5.60	2.31	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.06	1.38	0.55	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	6.98	1.05	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.64	1.02	0.82	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.50	1.44	0.72	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.38	0.72	1.76	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.54	2.28	3.65	2.51
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.98	0.00	0.84	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.58	1.20	1.79	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.84	0.96	1.23	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.41	0.37	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.16	1.14	1.43	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	5.47	3.79	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.22	3.65	2.28	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.95	2.56	0.26	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.26	1.83	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.01	2.16	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.65	2.82	0.24	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.82	2.37	0.34	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.18	3.54	1.57	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	2.32	0.00	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.40	2.88	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.37	4.46	1.12	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.82	3.12	1.20	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	7.33	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.73	2.69	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	2.15	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	3.90	2.92	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.40	3.20	2.13	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	2.45	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	3.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	4.20	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	1.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	9.53	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.15	4.74	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	4.87	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	4.43	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.24	3.79	1.03	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	3.67	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	3.18	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	3.54	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.99	3.43	0.31	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	2.37	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	2.75	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.91	4.45	0.49	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	4.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.00	5.09	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.28	7.66	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	13.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	6.34	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	10.92	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	22.24	10.71	0.82	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.73	2.58	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.84	2.92	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	3.06	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	11.10	1.89	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	10.89	2.78	0.93	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	4.27	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.38	2.57	1.13	0.92
mesothelioma cell line:Mero-25	10850-111F4	4.99	2.27	2.50	0.91
mesothelioma cell line:Mero-41	10851-111F5	7.58	2.20	0.49	1.22
mesothelioma cell line:Mero-48a	10852-111F6	10.63	3.99	1.55	1.33
mesothelioma cell line:Mero-82	10853-111F7	7.88	0.79	1.31	1.58
mesothelioma cell line:Mero-83	10854-111F8	9.19	3.06	1.02	2.04
mesothelioma cell line:Mero-84	10855-111F9	6.82	2.53	3.03	1.01
mesothelioma cell line:Mero-95	10856-111G1	6.21	2.48	2.90	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	6.46	4.31	1.82	2.15
mesothelioma cell line:NCI-H226	10846-111E9	6.15	2.53	1.99	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	5.98	3.93	0.68	3.07
mesothelioma cell line:NCI-H28	10845-111E8	19.34	5.85	0.51	4.33
mesothelioma cell line:No36	10857-111G2	1.96	1.96	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	8.40	2.71	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	19.96	3.84	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	30.04	4.76	1.34	0.73
migratory langerhans cells, donor3	11903-125F4	22.61	6.28	1.08	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.26	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.42	0.64	1.91	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.51	0.92	0.46	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.41	5.14	1.71	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	15.15	6.65	0.92	1.48
myeloma cell line:PCM6	10474-106I6	22.14	12.45	1.58	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	9.02	1.37	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.26	1.67	0.22	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.43	0.88	0.29	0.37
nasal epithelial cells, donor2	12227-129F4	17.11	2.21	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	12.65	8.74	0.46	3.68
neuroblastoma cell line:NB-1	10539-107G8	16.65	2.43	1.50	2.81
neuroblastoma cell line:NBsusSR	10607-108F4	12.23	2.32	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	10.81	3.91	1.12	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.51	3.08	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.20	3.01	0.32	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	6.64	1.41	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.18	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	7.19	1.33	0.27	1.86
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	12.68	10.65	0.51	5.07
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.81	2.40	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.90	2.56	0.00	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.41	2.36	1.31	1.58
nucleus accumbens, adult, pool1	10037-101F1	11.72	3.28	6.37	0.66
occipital cortex - adult, donor10196	10172-103C1	8.24	4.12	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	18.25	5.37	5.10	0.54
occipital cortex, newborn, donor10223	10355-105E4	7.64	1.46	3.64	0.36
occipital lobe, adult, donor1	10076-102A4	13.64	2.36	11.02	0.79
occipital lobe, fetal, donor1	10073-102A1	21.46	2.15	4.29	0.43
occipital pole, adult, pool1	10036-101E9	11.43	4.02	5.52	0.63
olfactory region, adult	10195-103E6	12.04	3.44	7.64	1.15
optic nerve, donor1	10277-104E7	16.01	0.00	8.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.00	2.39	0.11	1.59
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.17	2.47	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.10	1.19	0.34	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.36	1.73	0.81	2.43
osteoclastoma cell line:Hs 706.T	10704-109H2	4.41	2.35	2.06	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	0.00	0.93	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	10.82	1.91	0.85	1.06
ovary, adult, pool1	10020-101D2	20.53	1.66	1.14	1.75
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	7.15	0.92	1.47	0.55
pancreas, adult, donor1	10049-101G4	16.93	8.47	1.88	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.99	3.07	0.28	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	10.05	2.56	1.19	3.75
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.08	2.15	0.50	1.99
paracentral gyrus, adult, pool1	10035-101E8	11.17	3.39	6.22	0.55
parietal cortex, adult, donor10258	10373-105G4	2.94	3.67	5.87	1.47
parietal lobe - adult, donor10196	10171-103B9	7.52	0.00	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	14.54	2.57	4.56	0.57
parietal lobe, adult, pool1	10034-101E7	12.78	2.47	8.11	0.62
parietal lobe, fetal, donor1	10072-101I9	4.85	4.85	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	5.23	1.12	4.49	0.75
parotid gland, adult	10199-103F1	27.13	4.93	0.62	3.70
penis, adult	10200-103F2	16.65	4.30	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.16	3.72	0.37	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.03	2.62	1.17	2.04
pineal gland - adult, donor10196	10179-103C8	9.68	1.29	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	12.44	1.18	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	6.27	4.39	1.25	1.25
pituitary gland - adult, donor10196	10180-103C9	8.09	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	13.03	6.78	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	5.96	8.51	0.00	0.00
placenta, adult, pool1	10021-101D3	21.82	3.55	0.97	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	5.56	3.84	0.26	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.85	2.65	1.09	1.56
pons, adult, pool1	10033-101E6	11.71	2.32	8.09	0.43
postcentral gyrus, adult, pool1	10032-101E5	11.25	2.96	7.24	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	5.10	0.87	0.15	0.29
prostate cancer cell line:PC-3	10439-106E7	21.96	2.72	1.63	5.63
prostate, adult, pool1	10022-101D4	20.13	1.90	2.18	1.54
putamen, adult, donor10196	10176-103C5	15.58	1.42	5.43	0.47
putamen, adult, donor10252	10152-102I8	7.84	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	2.19	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.49	2.90	3.62	0.72
putamen, newborn, donor10223	10365-105F5	3.00	3.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	11.35	1.16	0.87	0.87
rectum, fetal, donor1	10067-101I4	23.65	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.78	2.54	0.42	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.46	0.41	0.41	0.41
retina, adult, pool1	10030-101E3	30.32	4.77	3.28	3.58
retinoblastoma cell line:Y79	10475-106I7	8.05	3.64	0.78	5.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	5.04	1.35	0.25	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	6.47	1.41	0.00	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	3.03	1.52	0.00	0.76
salivary acinar cells, donor1	11771-123I7	10.36	0.32	0.16	1.13
salivary acinar cells, donor2	11772-123I8	12.12	2.20	0.28	1.24
salivary acinar cells, donor3	11773-123I9	15.23	1.32	0.00	2.65
salivary gland, adult, pool1	10093-102C3	20.02	6.86	0.00	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	3.46	4.97	0.51	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	4.23	1.76	0.35	0.12
seminal vesicle, adult	10201-103F3	21.16	7.41	0.53	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.56	2.19	0.49	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.28	1.51	1.76	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	5.02	5.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.46	1.34	0.40	3.22
signet ring carcinoma cell line:Kato III	10436-106E4	16.80	3.76	1.44	1.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	25.16	1.81	1.42	6.58
skeletal muscle - soleus muscle, donor1	10282-104F3	12.06	2.84	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	26.27	6.24	1.08	3.84
skeletal muscle, fetal, donor1	10066-101I3	16.08	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	20.36	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	16.41	3.79	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	16.68	6.67	3.34	3.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	12.29	5.99	1.89	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	14.46	3.66	0.39	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	6.26	3.46	0.49	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	7.40	3.54	0.48	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.10	3.70	2.83	6.76
small intestine, adult, pool1	10024-101D6	40.61	2.03	0.60	3.94
small intestine, fetal, donor1	10064-101I1	17.94	1.72	0.25	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	3.08	2.56	4.10
smooth muscle, adult, pool1	10048-101G3	20.93	2.84	1.29	0.78
somatostatinoma cell line:QGP-1	10781-110G7	21.98	1.61	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	13.99	2.98	11.24	1.15
spinal cord, adult, donor10252	10159-103A6	16.95	7.49	3.94	0.39
spinal cord, adult, donor10258	10369-105F9	6.23	7.61	10.38	0.69
spinal cord, fetal, donor1	10056-101H2	15.25	3.66	6.71	1.22
spinal cord, newborn, donor10223	10359-105E8	6.43	0.46	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.31	1.19	1.49	1.34
spleen, adult, pool1	10025-101D7	15.53	3.96	1.21	2.53
spleen, fetal, pool1	10044-101F8	30.67	2.70	1.83	2.86
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.42	8.59	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	6.08	0.57	0.57	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	7.69	2.10	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	8.99	1.17	0.39	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	10.13	3.15	0.79	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.46	0.85	1.27	2.12
stomach, fetal, donor1	10062-101H8	21.36	5.34	1.07	1.07
submaxillary gland, adult	10202-103F4	20.51	3.99	0.00	2.28
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	21.81	3.95	11.01	0.83
substantia nigra, adult, donor10258	10371-105G2	5.17	3.10	9.31	0.52
substantia nigra, newborn, donor10223	10358-105E7	4.24	2.83	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1.83	0.92	0.69	0.46
temporal lobe, adult, pool1	10031-101E4	12.89	3.56	6.10	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	24.93	1.42	7.12	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	12.31	5.71	10.11	0.88
tenocyte, donor1	11763-123H8	15.01	1.05	1.75	1.05
tenocyte, donor2	11765-123I1	14.88	3.05	1.14	0.76
tenocyte, donor3	11768-123I4	12.97	0.37	0.00	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.96	6.80	0.68	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	8.94	3.55	0.62	0.77
teratocarcinoma cell line:PA-1	10807-111A6	4.65	1.86	0.46	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	7.24	2.03	0.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.54	0.00	1.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.96	0.33	0.76	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	3.58	1.95	0.00	0.00
testis, adult, pool1	10026-101D8	22.66	16.64	1.93	1.61
testis, adult, pool2	10096-102C6	10.83	28.42	1.35	0.90
thalamus - adult, donor10196	10168-103B6	11.04	3.31	8.83	0.00
thalamus, adult, donor10252	10154-103A1	21.57	3.75	10.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	9.24	15.40	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.78	2.31	8.89	0.33
thalamus, newborn, donor10223	10366-105F6	5.18	0.00	1.15	0.58
throat, adult	10209-103G2	23.47	1.50	0.50	4.49
throat, fetal, donor1	10061-101H7	15.24	2.74	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	5.37	5.56	0.99	0.99
thymus, adult, pool1	10027-101D9	13.52	9.05	3.38	0.99
thymus, fetal, pool1	10043-101F7	18.81	10.08	2.39	1.77
thyroid carcinoma cell line:KHM-5M	10776-110G2	11.17	2.79	1.46	2.53
thyroid carcinoma cell line:TCO-1	10783-110G9	18.30	2.93	0.98	1.82
thyroid, adult, pool1	10028-101E1	34.81	2.33	0.37	4.57
thyroid, fetal, donor1	10060-101H6	20.04	1.85	1.85	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	6.16	3.08	0.00
tongue, adult	10203-103F5	15.82	2.56	0.93	1.63
tongue, fetal, donor1	10059-101H5	15.76	1.58	0.79	1.97
tonsil, adult, pool1	10047-101G2	38.47	3.31	1.20	2.91
trachea, adult, pool1	10029-101E2	17.01	2.70	0.65	1.96
trachea, fetal, donor1	10058-101H4	14.62	1.92	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	11.34	0.00	1.77	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	10.54	3.24	0.51	4.56
transitional-cell carcinoma cell line:JMSU1	10492-107B6	16.14	2.19	0.78	0.94
tridermal teratoma cell line:HGRT	10694-109G1	1.90	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	10.75	1.95	0.42	0.93
umbilical cord, fetal, donor1	10057-101H3	12.52	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	16.72	3.58	1.19	1.19
uterus, fetal, donor1	10055-101H1	12.29	3.07	0.51	1.02
vagina, adult	10204-103F6	18.09	1.94	0.65	0.65
vein, adult	10191-103E2	17.32	2.63	0.88	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.22	4.27	0.80	1.07